Stay updated on OV101 in Fragile X Syndrome: Clinical Trial
Sign up to get notified when there's something new on the OV101 in Fragile X Syndrome: Clinical Trial page.

Latest updates to the OV101 in Fragile X Syndrome: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange Detected- The page revision label updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page shows a minor revision label update from v3.4.0 to v3.4.1; there are no substantive changes to the study details, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedAdministrative UI and documentation updates were applied: glossary toggle options (Show/Hide glossary) and small wording changes related to QC criteria and the No FEAR Act data, plus a revision bump from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check40 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous v3.3.3 label.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded a dedicated Locations section listing site locations (California, Colorado, Illinois, Maryland, Ohio, Tennessee) and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure link and the prior state-location entries.SummaryDifference0.8%

- Check91 days agoChange DetectedPublication section now clarifies that entries are automatically filled from PubMed. Revision number updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to OV101 in Fragile X Syndrome: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OV101 in Fragile X Syndrome: Clinical Trial page.